Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 4;37(3):489–498. doi: 10.1111/jgh.15717

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

PMC Copyright notice

Balloon plots showing that some of the psychological factors (as per Rome III Psychosocial Alarm Questionnaire) initially and during follow‐up were associated with the development functional gastrointestinal disorders (FGIDs) among the patients with coronavirus disease‐19 (COVID‐19). CBD, chronic bowel dysfunction; IBS, irritable bowel syndrome; UD, uninvestigated dyspepsia. Figures in row (a) present data on anxiety questions, row (b) depression questions, and row (c) body pain questions at 1, 3, and 6 months, respectively. For P values, refer to Table 3. (a) , 150; , 100; , 50; , 0; . (b) , 150; , 100; , 50; , 0; . (c) , 150; , 100; , 50; , 0; .

Inline graphic — Balloon plots showing that some of the psychological factors (as per Rome III Psychosocial Alarm Questionnaire) initially and during follow‐up were associated with the development functional gastrointestinal disorders (FGIDs) among the patients with coronavirus disease‐19 (COVID‐19). CBD, chronic bowel dysfunction; IBS, irritable bowel syndrome; UD, uninvestigated dyspepsia. Figures in row (a) present data on anxiety questions, row (b) depression questions, and row (c) body pain questions at 1, 3, and 6 months, respectively. For P values, refer to Table 3. (a) , 150; , 100; , 50; , 0; . (b) , 150; , 100; , 50; , 0; . (c) , 150; , 100; , 50; , 0; .